Joyance Partners

Type

Venture Capital

Status

Active

Location

San Francisco, United States

Total investments

96

Average round size

2M

Portfolio companies

72

Rounds per year

13.71

Lead investments

4

Follow on index

0.21

Stages of investment
SeedEarly Stage Venture
Areas of investment
BiotechnologySoftwareArtificial IntelligenceFood and BeverageFitnessHealth CareWellnessMedical DeviceMedicalPersonal Health

Summary

Joyance Partners appeared to be the VC, which was created in 2017. The venture was found in North America in United States. The main office of represented VC is situated in the San Francisco.

Among the most popular portfolio startups of the fund, we may highlight Basis, Smilo, Finless Foods. Among the most popular fund investment industries, there are Artificial Intelligence, Medical Device. The fund has no specific favorite in a number of founders of portfolio startups. When startup sums 4 or 5+ of the founder, the probability for it to get the investment is little. For fund there is a match between the location of its establishment and the land of its numerous investments - United States. Besides, a startup needs to be aged 2-3 years to get the investment from the fund.

The fund is constantly included in 13-24 investment rounds annually. The important activity for fund was in 2018. Deals in the range of 1 - 5 millions dollars are the general things for fund. Considering the real fund results, this VC is 18 percentage points less often commits exit comparing to other organizations. The average startup value when the investment from Joyance Partners is 5-10 millions dollars.

The fund was created by William Lohse. We also calculated 6 valuable employees in our database.

The usual cause for the fund is to invest in rounds with 3-4 partakers. Despite the Joyance Partners, startups are often financed by Social Starts, Venture Kick, Plug and Play. The meaningful sponsors for the fund in investment in the same round are Y Combinator, Social Starts, UpHonest Capital. In the next rounds fund is usually obtained by Social Starts, DigiTx Partners, MassChallenge Switzerland.

Show more

Investor highlights

Industry focus
FoodtechHealthcareBiotech/Life SciencesWellness & FitnessClimate tech Show 1 more
Stage focus
Series APre-SeedSeed
Geo focus
AlbaniaAustriaBelgiumBosnia and HerzegovinaBulgaria Show 51 more

Discover reliable insights

Find relevant VC investors, identify key contacts and secure funding opportunities.

Investments analytics

Last fund

Fund size
EUR 2750000
Fund raised date
2019-05-01

Analytics

Total investments
96
Lead investments
4
Rounds per year
13.71
Follow on index
0.21
Investments by industry
  • Health Care (47)
  • Biotechnology (25)
  • Medical Device (15)
  • Food and Beverage (14)
  • Wellness (13)
  • Show 78 more
Investments by region
  • United States (54)
  • Switzerland (6)
  • Germany (10)
  • Canada (2)
  • Israel (2)
  • Show 7 more
Peak activity year
2020

Discover reliable insights

Leverage validated data, identify key contacts and secure funding opportunities for your business.

Quantitative data

Avg. startup age at the time of investment
4
Avg. valuation at time of investment
986K
Group Appearance index
0.86

Need more data?

Get access to full data about investors, including their team, contact information, and historic data.

Latest deals

Company name Deal date Industry Deal stage Deal size Location
Cellugy 21 May 2024 Biotechnology Seed 5M Central Denmark Region, Aarhus, Denmark
Cure Hydration 17 Apr 2023 Food and Beverage, Organic Food, Organic Early Stage Venture 5M United States, New York, New York
How we get our data

At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).

Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.